These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 35641486

  • 1. Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failure.
    Gehrke N, Wörns MA, Mann A, Hövelmeyer N, Waisman A, Straub BK, Galle PR, Schattenberg JM.
    Cell Death Dis; 2022 May 31; 13(5):510. PubMed ID: 35641486
    [Abstract] [Full Text] [Related]

  • 2. Cystathionine γ-lyase deficiency protects mice from galactosamine/lipopolysaccharide-induced acute liver failure.
    Shirozu K, Tokuda K, Marutani E, Lefer D, Wang R, Ichinose F.
    Antioxid Redox Signal; 2014 Jan 10; 20(2):204-16. PubMed ID: 23758073
    [Abstract] [Full Text] [Related]

  • 3. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis.
    Li R, Yang W, Yin Y, Zhang P, Wang Y, Tao K.
    Oxid Med Cell Longev; 2021 Jan 10; 2021():9932099. PubMed ID: 34457120
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N, Hövelmeyer N, Waisman A, Straub BK, Weinmann-Menke J, Wörns MA, Galle PR, Schattenberg JM.
    J Hepatol; 2018 May 10; 68(5):986-995. PubMed ID: 29366909
    [Abstract] [Full Text] [Related]

  • 5. Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure Through Inhibiting GSK3β-Nrf2-Mediated Hepatocyte Apoptosis and Ferroptosis.
    Huang S, Wang Y, Xie S, Lai Y, Mo C, Zeng T, Kuang S, Deng G, Zhou C, Chen Y, Huang S, Gao L, Lv Z.
    Cell Mol Gastroenterol Hepatol; 2022 May 10; 13(6):1649-1672. PubMed ID: 35202887
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS/d-GalN-induced acute liver failure in mice.
    Gong X, Yang Y, Huang L, Zhang Q, Wan RZ, Zhang P, Zhang B.
    Int Immunopharmacol; 2017 May 10; 46():124-132. PubMed ID: 28282576
    [Abstract] [Full Text] [Related]

  • 8. 4-hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice.
    Wang H, Wei X, Wei X, Sun X, Huang X, Liang Y, Xu W, Zhu X, Lin X, Lin J.
    Int Immunopharmacol; 2020 Jun 10; 83():106445. PubMed ID: 32272395
    [Abstract] [Full Text] [Related]

  • 9. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ, Cho HI, Kim SJ, Park JH, Kim JS, Kim YH, Lee SK, Kwak JH, Lee SM.
    Eur J Pharmacol; 2014 Sep 05; 738():66-73. PubMed ID: 24877692
    [Abstract] [Full Text] [Related]

  • 10. Kaempferol protects mice from d-GalN/LPS-induced acute liver failure by regulating the ER stress-Grp78-CHOP signaling pathway.
    Wang H, Chen L, Zhang X, Xu L, Xie B, Shi H, Duan Z, Zhang H, Ren F.
    Biomed Pharmacother; 2019 Mar 05; 111():468-475. PubMed ID: 30594786
    [Abstract] [Full Text] [Related]

  • 11. Deletion or inhibition of SphK1 mitigates fulminant hepatic failure by suppressing TNFα-dependent inflammation and apoptosis.
    Avni D, Harikumar KB, Sanyal AJ, Spiegel S.
    FASEB J; 2021 Mar 05; 35(3):e21415. PubMed ID: 33566377
    [Abstract] [Full Text] [Related]

  • 12. TAT-apoptosis repressor with caspase recruitment domain protein transduction rescues mice from fulminant liver failure.
    An J, Harms C, Lättig-Tünnemann G, Sellge G, Mandić AD, Malato Y, Heuser A, Endres M, Trautwein C, Donath S.
    Hepatology; 2012 Aug 05; 56(2):715-26. PubMed ID: 22392694
    [Abstract] [Full Text] [Related]

  • 13. Genipin protects lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice.
    Kim SJ, Kim JK, Lee DU, Kwak JH, Lee SM.
    Eur J Pharmacol; 2010 Jun 10; 635(1-3):188-93. PubMed ID: 20303938
    [Abstract] [Full Text] [Related]

  • 14. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Ben Ari Z, Avlas O, Pappo O, Zilbermints V, Cheporko Y, Bachmetov L, Zemel R, Shainberg A, Sharon E, Grief F, Hochhauser E.
    Cell Physiol Biochem; 2012 Jun 10; 29(1-2):41-50. PubMed ID: 22415073
    [Abstract] [Full Text] [Related]

  • 15. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Jin Q, Jiang S, Wu YL, Bai T, Yang Y, Jin X, Lian LH, Nan JX.
    Phytomedicine; 2014 Jan 15; 21(2):141-7. PubMed ID: 24011530
    [Abstract] [Full Text] [Related]

  • 16. Endoplasmic reticulum stress-activated glycogen synthase kinase 3β aggravates liver inflammation and hepatotoxicity in mice with acute liver failure.
    Ren F, Zhou L, Zhang X, Wen T, Shi H, Xie B, Li Z, Chen D, Wang Z, Duan Z.
    Inflammation; 2015 Jan 15; 38(3):1151-65. PubMed ID: 25630719
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of UII/UTR system relieves acute inflammation of liver through preventing activation of NF-κB pathway in ALF mice.
    Liang DY, Liu LM, Ye CG, Zhao L, Yu FP, Gao DY, Wang YY, Yang ZW, Wang YY.
    PLoS One; 2014 Jan 15; 8(6):e64895. PubMed ID: 23755157
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis.
    Chen L, Ren F, Zhang H, Wen T, Piao Z, Zhou L, Zheng S, Zhang J, Chen Y, Han Y, Duan Z, Ma Y.
    PLoS One; 2012 Jan 15; 7(9):e45202. PubMed ID: 23028846
    [Abstract] [Full Text] [Related]

  • 19. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
    Kang JW, Kim DW, Choi JS, Kim YS, Lee SM.
    Food Chem Toxicol; 2013 Jul 15; 57():132-9. PubMed ID: 23535186
    [Abstract] [Full Text] [Related]

  • 20. Farnesyltransferase inhibitor, tipifarnib, prevents galactosamine/lipopolysaccharide-induced acute liver failure.
    Shirozu K, Hirai S, Tanaka T, Hisaka S, Kaneki M, Ichinose F.
    Shock; 2014 Dec 15; 42(6):570-577. PubMed ID: 25046541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.